Rhythm Pharma (RYTM) stock surges as the firm advances its lead asset setmelanotide into a Phase 3 trial in Prader-Willi syndrome after Phase 2 data. Read more here.
As it kicks off a pivotal phase 3 trial of its investigational treatment for Angelman syndrome (AS), Ionis Pharmaceuticals is ...
In a recent, vulnerable Instagram post, the Trainwreck star addressed rumors surrounding her marriage to Chris Fischer, as well as insight into her major weight loss journey. “I didn’t lose 30lbs, I ...
Mast cell activation syndrome is a condition that causes mast cells to release an inappropriate amount of chemicals into your body. This causes allergy symptoms and a wide range of other symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results